Dr. Dreicer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1240 Lee St
Charlottesville, VA 22908Phone+1 434-924-9333Fax+1 434-244-7526
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1986 - 1989
Indiana University School of MedicineResidency, Internal Medicine, 1983 - 1986
McGovern Medical School at UTHealthClass of 1983
Certifications & Licensure
CA State Medical License 2002 - Present
VA State Medical License 2015 - 2026
OH State Medical License 1999 - 2017
NY State Medical License 2002 - 2016
PA State Medical License 2002 - 2016
MI State Medical License 2002 - 2015
IL State Medical License 2002 - 2005- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- First-in-human Study of CCW702 in Patients With Metastatic Castration Resistant Prostate Cancer Start of enrollment: 2020 Jul 17
Publications & Presentations
PubMed
- 1470 citationsAtezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.Arjun Vasant Balar, Matthew D. Galsky, Jonathan E. Rosenberg, Thomas Powles, Daniel P. Petrylak
Lancet. 2017-01-07 - 605 citationsChemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED TrialChristos Kyriakopoulos, Yu-Hui Chen, Michael A. Carducci, Glenn Liu, David F. Jarrard
Journal of Clinical Oncology. 2018-01-31 - 991 citationsTrial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3Howard I. Scher, Michael J. Morris, Walter M. Stadler, Celestia S. Higano, Ethan Basch
Journal of Clinical Oncology. 2016-09-27
Press Mentions
Prostate Cancer Death Risk Varies by Histologic SubtypeAugust 23rd, 2024- Drop in Screenings Linked to Increase in Advanced Prostate Cancer CasesOctober 28th, 2022
- Comprehensive Genetic Risk Score May Predict Risk of Developing Metastatic Prostate Cancer or Death from Prostate Cancer Across Diverse PopulationsFebruary 18th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
